Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-21 of 21
1-21 of 21
Filter
Colby Watkins
COO at WherezHemp
absorption (pharmacology), alternative medicine, amazon (company), anti-inflammatory, anti-predator adaptation, appetite, aromatherapy, audit, bank, behavior, blog, blood alcohol content, book, botany, brand, brand loyalty, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, chemical substance, coffee, coffee bean, coffeehouse, communication, communication protocol, community, competition, customer relationship management, dose (biochemistry), drink, due diligence, email, email spam, emerging market, entourage effect, essential oil, facebook, food, food and drug administration, globalization, gluten-free diet, good manufacturing practice, google, hemp, herbal distillate, hindsight bias, insurance, juice, lemon, ligand (biochemistry), limonene, linkedin, mango, margin of error, medication, nsf international, nutraceutical, opt-in email, organic certification, pain, peer-to-peer, price, reason, red bull, regulatory compliance, risk management, sales, sales process engineering, secondary metabolite, social media, software , solvent, spectrum, starbucks, target corporation, telecommuting, terpene, terpenoid, tetrahydrocannabinol, trade, walmart, water, water activity, youtube
Michael Flemmens
VP of Technical Business Development at SōRSE Technology
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, attention, blinded experiment, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis industry, chemical substance, clinicaltrials.gov, coffee, coffee bean, coffeehouse, coronavirus disease 2019, diesel fuel, distillation, dose (biochemistry), food, food and drug administration, hospital, ibuprofen, in vitro, innovation, laboratory, ligand (biochemistry), medication, molecule, nutraceutical, pain, pharmaceutical industry, pharmacokinetics, randomized controlled trial, red bull, solvent, starbucks, steam distillation, supercritical fluid, tetrahydrocannabinol, women's health
Austin Rhodus
Director Of Membership Services at Midwest Hemp Council
absorption (pharmacology), alternative medicine, anti-predator adaptation, appetite, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, dose (biochemistry), food, ligand (biochemistry), medication, nutraceutical, pain, red bull, solvent, starbucks, tetrahydrocannabinol
Blair Curless
Clinical Pharmacist at Phoebe Putney Health System
absorption (pharmacology), advertising, analgesic, anti-inflammatory, aphria (company), bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, class action, coffee, cosmetics, damages, dietary supplement, distribution (marketing), doctor of pharmacy, dose (biochemistry), drug, euphoria, false advertising, federal trade commission, flavor, food, food and drug administration, hemp, interleukin 17, kool-aid, law, lawsuit, ligand (biochemistry), marketplace, medical cannabis, medication, mountain dew, nestea, new drug application, nonsteroidal anti-inflammatory drug, novel food, opioid, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, pricing, product testing, recycling, regulatory compliance, retail, route of administration, shelf life, social media, soft drink, sublingual administration, tea, tetrahydrocannabinol, tetrahydrocannabivarin, toast (honor), topical medication
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Charles Piermarini
CEO at Restorative CBD
absorption (pharmacology), adoption, allosteric regulation, anti-inflammatory, anticoagulant, anticonvulsant, antiviral drug, benzodiazepine, bioavailability, breathing, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), certificate of analysis, clinical trial, coronavirus disease 2019, cytochrome p450, dietary supplement, dose (biochemistry), drug, drug interaction, drug overdose, flax, geriatrics, grapefruit–drug interactions, infection, inhaler, insomnia, ligand (biochemistry), lung volumes, medical cannabis, medication, melatonin, nanotechnology, omega-3 fatty acid, omega-6 fatty acid, opioid, over-the-counter drug, oxycodone/paracetamol, pain, patient, pharmaceutical industry, pharmacology, pharmacy, prothrombin time, pulmonary embolism, risk, route of administration, sense, serotonin, serotonin syndrome, signal transduction, sleep disorder, stroke, terpene, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, warfarin
Najifa Choudhury
Ambulatory Care Pharmacist at PACE SEMI
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis (drug), cannabis edible, certificate of analysis, clinical trial, cytochrome p450, doctor of pharmacy, dose (biochemistry), drug interaction, drug overdose, euphoria, geriatrics, grapefruit–drug interactions, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, opioid, over-the-counter drug, oxycodone/paracetamol, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, prothrombin time, pulmonary embolism, route of administration, signal transduction, stroke, sublingual administration, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Cohin Kakar
Chief Marketing Officer at The Anthos Group
absorption (pharmacology), analgesic, anticoagulant, anticonvulsant, appetite, benzodiazepine, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, certificate of analysis, chemotherapy, clinical trial, cytochrome p450, dementia, doctor of pharmacy, dose (biochemistry), drug development, drug interaction, drug overdose, euphoria, fibromyalgia, food and drug administration, geriatrics, grapefruit–drug interactions, headache, inflammation, interleukin 17, ligand (biochemistry), medication, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, opioid epidemic in the united states, over-the-counter drug, oxycodone/paracetamol, personalized medicine, pharmaceutical formulation, pharmacogenomics, pharmacology, pharmacy, pharmacy school, placebo, prothrombin time, pulmonary embolism, route of administration, sensitivity and specificity, signal transduction, stroke, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabivarin, therapeutic index, topical medication, warfarin
Lola O Ohonba
Certified Medical Cannabist Specialist at WCI Health
absorption (pharmacology), alternative medicine, analgesic, anti-inflammatory, anti-predator adaptation, antidepressant, anxiolytic, appetite, bioavailability, blood alcohol content, botany, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis industry, chemical substance, coffee, coffee bean, coffeehouse, democratic party (united states), doctor of pharmacy, dose (biochemistry), entourage effect, euphoria, food, food and drug administration, gerrymandering, interleukin 17, ligand (biochemistry), major depressive disorder, mechanism of action, medical cannabis, medication, neuroplasticity, neurotransmitter, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pain, pharmaceutical formulation, pharmacology, pharmacy, pharmacy school, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, red bull, route of administration, sense, serotonin, solvent, starbucks, sublingual administration, swing state, tetrahydrocannabinol, tetrahydrocannabivarin, topical medication
Joseph Friedman
Consultant, National Speaker, Medical Cannabis Pharmacist
absorption (pharmacology), analgesic, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis edible, cannabis strain, clinical trial, delta-8-tetrahydrocannabinol, doctor of pharmacy, dose (biochemistry), euphoria, first pass effect, high-performance liquid chromatography, institutional review board, interleukin 17, ligand (biochemistry), lipophilicity, mass spectrometry, medication, natural product, nonsteroidal anti-inflammatory drug, nutraceutical, opioid, pharmaceutical formulation, pharmacokinetics, pharmacology, pharmacy, pharmacy school, route of administration, sublingual administration, synthetic cannabinoids, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, topical medication, waters corporation
Luis Enrique Weyback
Founder and President at Doctor Jane
absorption (pharmacology), allergy, alzheimer's disease, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chronic stress, chronic traumatic encephalopathy, clinical trial, concussion, cortisol, cortisone, crohn's disease, cytokine, dietary supplement, disease, doping in sport, dose (biochemistry), drug overdose, emergency department, fluid replacement, food, food allergy, gastrointestinal tract, grapefruit–drug interactions, healing, heart, herbal medicine, heroin, hypertension, ibuprofen, inflammation, medical cannabis, medication, medicine, naproxen, neurology, neurosurgery, nicotine, nonsteroidal anti-inflammatory drug, opioid, opioid overdose, pain, pharmaceutical industry, pharmacokinetics, reactive oxygen species, route of administration, stress (biology), surgery, tetrahydrocannabinol, therapy, trpv1, tumor necrosis factor-alpha, vasodilation, wound
Jennah Noegel
Chief Operating Officer at Gruene Cross Health & Wellness
absorption (pharmacology), allergy, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), food allergy, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hypertension, opioid, pain, route of administration, stress (biology), tetrahydrocannabinol, therapy, tumor necrosis factor-alpha
Roger Bryant
Owner at Evolve Distributions
absorption (pharmacology), allergy, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), food allergy, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hypertension, opioid, pain, route of administration, stress (biology), tetrahydrocannabinol, therapy, tumor necrosis factor-alpha
Rob Streisfeld
CEO at BeyondBrands
absorption (pharmacology), allergy, alternative medicine, appetite, bioavailability, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, chemotherapy, chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), endocannabinoid system, endocrinology, epilepsy, food allergy, food and drug administration, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hormone, hypertension, obesity, opioid, pain, probiotic, route of administration, selective serotonin reuptake inhibitor, sleep, stress (biology), synthetic cannabinoids, tetrahydrocannabinol, therapy, traditional chinese medicine, tumor necrosis factor-alpha, vitamin c, well-being
Keiko Beatie
Director of Education & Programming Coral Cove Cannabis Jamaica Holistic Ayurvedic Chinese Medicine at Green Wave Relations
absorption (pharmacology), acne, aesthetics, agriculture, allergy, american broadcasting company, anxiety, anxiety disorder, arthritis, attention, ayurveda, belief, bioavailability, brand, broadcast syndication, cake, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cbs, certificate of analysis, chemical peel, china, chinese herbology, chronic pain, chronic stress, clinical trial, cortisol, cosmetics, crohn's disease, cytokine, dementia, design, dietary supplement, dose (biochemistry), drug, drug overdose, drug rehabilitation, endocannabinoid system, ethanol, federal aviation administration, flower, food, food allergy, food and drug administration, fox broadcasting company, gastrointestinal tract, good manufacturing practice, grapefruit–drug interactions, grocery store, haircare, health care, heat, hemp, herbal medicine, hypertension, law, lawyer, lotion, medical cannabis, medication, medicine, medium-chain triglyceride, mental disorder, mood (psychology), nbc, news, nutraceutical, opiate, opioid, organic certification, osteoarthritis, packaging and labeling, packaging, and labeling, pain, pain management, percentage, pesticide, pharmaceutical industry, prescription drug, pricing, psilocybin, qr code, reputation, retail, route of administration, runway, seed, separation anxiety disorder, shelf life, soap, solubility, stress (biology), substance dependence, tablet (pharmacy), tea, tetrahydrocannabinol, textbook, therapy, traditional chinese medicine, tumor necrosis factor-alpha, united states department of agriculture, veterinarian
Marcus Najera
Founder at Cannabis Science Talk
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, dose (biochemistry), emotion, enzyme, hash oil, liposome, memory, micelle, milk, nanotechnology, neuroimaging, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol
Jackson Rowland
CEO at Green Genomix
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, dose (biochemistry), emotion, enzyme, hash oil, liposome, memory, micelle, milk, nanotechnology, neuroimaging, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol
Carter Baird
R&D Laboratory Technician at United Cannabis Corporation
absorption (pharmacology), alternative medicine, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), chemist, concussion, crohn's disease, cytochrome p450, dose (biochemistry), drink, emotion, endocannabinoid system, entourage effect, enzyme, gpr55, hash oil, immune system, immunodeficiency, liposome, liquor, memory, micelle, milk, moonshine, nanotechnology, neuroimaging, neuron, pharmaceutical industry, pharmacokinetics, pharmacology, prohibition, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol, weight training
Chris Denicola
CEO & Co-Founder at Prism Science and Santeer
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, dose (biochemistry), emotion, enzyme, hash oil, liposome, memory, micelle, milk, nanotechnology, neuroimaging, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, tetrahydrocannabinol
Emek Blair
Founder and Chief Scientist at Puffin Hemp
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chemist, clinical trial, concussion, cytochrome p450, dietary supplement, disease, dose (biochemistry), drug overdose, emergency department, emotion, enzyme, food, hash oil, heroin, liposome, medical cannabis, medication, memory, micelle, milk, nanotechnology, neuroimaging, neurology, neurosurgery, nicotine, opioid overdose, pharmaceutical industry, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, surgery, tetrahydrocannabinol, therapy
Kevin Schmidt
Director of Research & Development at Centuria Foods
absorption (pharmacology), adele, android (operating system), ann arbor, michigan, bank of america, bioavailability, blood sugar level, california, canada, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, chemist, concussion, cytochrome p450, debate, dose (biochemistry), dvd, emotion, enzyme, hash oil, heavy metal music, ice cream, illinois, liposome, memory, micelle, michael jackson, microphone, milk, muhammad ali, nanotechnology, neuroimaging, new york city, news, ohio, pharmacokinetics, psalms, receptor (biochemistry), receptor antagonist, reggae, snow removal, spotify, surfactant, tetrahydrocannabinol, united states
1
1-21 of 21